This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-265363-xw56intn | defining influenza- like illness clinically Statins: panacea for sepsis? |
| cord-032016-2rzszcke | -What ’s the Catch? |
| cord-275556-798oed8n | -cov-2 in a high transmission setting increases 167 the risk of severe covid-19 compared to exposure to a low transmission setting? |
| cord-010162-hfo35gsq | A second question is, how effective is the antibiotic treatment in mycoplasmal pneumonias? |
| cord-010162-hfo35gsq | effect of reinfection and passive protection by immune serum Saikku't? |
| cord-279111-jaa45kyc | Mycoplasma pneumoniae infection in primary care investigated by real- time PCR in England and Wales Increased incidence of Mycoplasma pneumoniae infections detected by laboratory- based surveillance in Denmark in 2010 Prevalence, diagnosis, and disease course of pertussis in adults with acute cough in primary care Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabs Rhinovirus and coronavirus infections Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza- like illness Design and validation of consensus- degenerate hybrid oligonucleotide primers for broad and sensitive detection of corona- and toroviruses Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness Prolonged shedding of rhinovirus and re- infection in adults with respiratory tract illness Evidence of human bocavirus circulating in children and adults Comorbidity and high viral load linked to clinical presentation of respiratory human bocavirus infection Human bocavirus: passenger or pathogen in acute respiratory tract infections? |
| cord-279111-jaa45kyc | The novel KI, WU, MC polyomaviruses: possible human pathogens? |
| cord-257248-aii0tj9x | A prospective study of agents associated with acute respiratory infection among young American Indian children Three- weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo- controlled trial Upper airway viruses and bacteria detection in clinical pneumonia in a population with high nasal colonisation do not relate to clinical signs Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries Evidence for a causal relationship between respiratory syncytial virus infection and asthma Does the microbiota regulate immune responses outside the gut? |
| cord-257248-aii0tj9x | Viral bacterial co- infection of the respiratory tract during early childhood Cough formation in viral infections in children Is virus coinfection a predictor of severity in children with viral respiratory infections? |
| cord-275068-yr076sl6 | A patients to stay home 12 or tell everyone to take vitamin D or get vaccinated with BCG? |
| cord-275068-yr076sl6 | What are the mechanisms underlying 13 these relationships? |
| cord-318021-4qrf5m8s | Should International Classification of Diseases codes be used to survey hospitalacquired pneumonia? |
| cord-286525-0354438s | The role of IL-6 and other mediators in the cytokine storm associated with SARS- CoV-2 infection Dexamethasone in Hospitalized Patients with Covid-19-Preliminary Report Is a"Cytokine Storm"Relevant to COVID-19? Efficacy of Tocilizumab in COVID-19: A Systematic review and Meta- Analysis Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases Confounding by Indication in Clinical Research Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta- analysis Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19( Metcovid): |
| cord-286525-0354438s | ado about nothing? |
| cord-008258-5v55vv4s | : is it'much ado about nothing'? |
| cord-008258-5v55vv4s | How low is the risk of influenza A( H5N1) infection? |
| cord-008258-5v55vv4s | cord-008258- 5v55vv4s authors: Raoult, D. title: Is it the end of the nervous breakdown on avian influenza? |
| cord-276212-ys5njiw0 | NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong Are meteorological parameters associated with acute respiratory tract infections? |
| cord-295479-mcfqs7vf | Post- COVID-19 chronic symptoms: a post- infectious entity? |
| cord-300023-2dg7njki | How long do nosocomial pathogens persist on inanimate surfaces? |
| cord-019490-m1cuuehi | The origin of CRP and GSH in CSF is unknown( production in CNS and/or from blood due to blood- brain barrier permeability increasing?). |
| cord-023592-w96h4rir | tigecycline the answer? |
| cord-293542-o0zspgrk | Global trends in emerging infectious diseases Climate change and infectious disease: a dangerous liaison? |
| cord-293542-o0zspgrk | How prepared is Europe for pandemic influenza? |
| cord-009675-utz0iazs | Are point‐of‐care( POC) virological tests what is needed? |
| cord-009675-utz0iazs | Does it make sense? |
| cord-009675-utz0iazs | Not influenza virus? |
| cord-009675-utz0iazs | The importance of specific virus diagnosis and monitoring for antiviral treatment Total quality management in clinical virology laboratories Quality control in nucleic acid testing- where do we stand? |
| cord-009675-utz0iazs | Then what is the patient suffering from? |
| cord-009675-utz0iazs | Training to become proficient takes time and experience; are those clinicians who might use POC tests willing to acquire a similar proficiency in virology, as well as in their own clinical specialty? |
| cord-314288-6vh7dvad | Or prescribed by some physicians, or units, and not by others? |
| cord-314288-6vh7dvad | Or the other way around, to those patients perceived to stand a better chance? |
| cord-314288-6vh7dvad | Or to opinionated patients with opinionated families? |
| cord-314288-6vh7dvad | Or( in some settings) to those who can pay? |
| cord-314288-6vh7dvad | Was the new treatment given to the worst patients? |
| cord-022501-9wnmdvg5 | Is erysipelas- associated Tinea pedis a site of streptococcal colonisation? |
| cord-022501-9wnmdvg5 | Is it necessary to incubate the BacT/ Alert blood culture bottles more than 3 days? |
| cord-022501-9wnmdvg5 | Regarding MEPM, it was 85.9% for 500 mg gid? and |
| cord-314808-ssiggi2z | Can it happen here? |
| cord-314808-ssiggi2z | In the case of BSE, fear rapidly extended to other countries[ 18, 19] and continents[ 20][ 21][ 22], aided by coverage of the subject in well respected journals of medical and general interest; in the latter case, with eye- catching titles such as'can it happen here?'. |
| cord-314808-ssiggi2z | Now it's our turn Japan's first BSE case fuels fears elsewhere Reaction to the threat of influenza pandemic: the mass media and the public Avian flu: the creation of expectations in the interplay between science and the media Effects of episodic variations in web- based avian influenza education: influence of fear and humor on perception, comprehension, retention and behavior A crisis: fear toward a possible H5N1 pandemic Survey of hospital healthcare personnel response during a potential avian influenza pandemic: will they come to work? |
| cord-314808-ssiggi2z | Now, a Chinese passenger sits in a nearby seat; the specialist is transiently overwhelmed by fears: what if this person is a carrier; what should one do if this fellow passenger coughs? |
| cord-314808-ssiggi2z | Why is it that infectious diseases cause the most significant psychological unrest, both in the public and in health professionals alike? |
| cord-314808-ssiggi2z | an attack scenario Are there characteristics of infectious diseases that raise special ethical issues? |
| cord-279125-w6sh7xpn | , 33 Plate reading Is there bacterial growth on the plate? |
| cord-279125-w6sh7xpn | 13 a narrative review of current applications Machine Learning for Healthcare: On the Verge of a Major Shift in 118 Supervised machine learning for the prediction of infection on admission 18 to hospital: a prospective observational cohort study Using artificial intelligence to reduce 21 diagnostic workload without compromising detection of urinary tract infections Unsupervised extraction of epidemic syndromes from participatory influenza stewardship: fair enough? |
| cord-279125-w6sh7xpn | Expert system Does the detected resistance profile make sense? |
| cord-279125-w6sh7xpn | How reliable is the analytical performance of a test? |
| cord-279125-w6sh7xpn | Imaging Are there bacteria on the microscope slide? |
| cord-279125-w6sh7xpn | Is there a potential bacterial phenotype? |
| cord-279125-w6sh7xpn | Public Health Is there a potential outbreak? |
| cord-279125-w6sh7xpn | The Promise of the Internet of 4 Things in Healthcare: How Hard Is It to Keep? |
| cord-279125-w6sh7xpn | of resistance by analysing MALDI- TOF spectra 43, 44 Sepsis treatment What is the best treatment for the patient? |
| cord-009664-kb9fnbgy | ( Symposium arranged with EFWISG) S460 MRSA in food products: cause for concern or case for complacency? |
| cord-009664-kb9fnbgy | And are we gaining or losing? |
| cord-009664-kb9fnbgy | And the equally valid question: to what extent does biological science benefit from study of fungi that are opportunistic pathogens? |
| cord-009664-kb9fnbgy | Are we aware? |
| cord-009664-kb9fnbgy | Are we in command? |
| cord-009664-kb9fnbgy | Clinical microbiology − is outsourcing the way to go? |
| cord-009664-kb9fnbgy | Do the efflux pump inhibitors reserpine and verapamil reduce the mutation frequency? |
| cord-009664-kb9fnbgy | Do we have a choice? |
| cord-009664-kb9fnbgy | Do we know where we are going? |
| cord-009664-kb9fnbgy | Do we recognise a driving force other than money? |
| cord-009664-kb9fnbgy | Does efflux phenotype impose a fitness cost? |
| cord-009664-kb9fnbgy | Emerging infections: can we cope with them? |
| cord-009664-kb9fnbgy | Furthermore, is there a pathophysiological impact of viral replication in individuals with CIHHV-6? |
| cord-009664-kb9fnbgy | If you do n't look for them, you wo n't find them: anaerobes revisited S481 Anaerobic microbiota of the mouth − friend or foe? |
| cord-009664-kb9fnbgy | Is it good, bad or just plain necessary? |
| cord-009664-kb9fnbgy | MRSA screening − will we ever agree? |
| cord-009664-kb9fnbgy | O391 Throwing caution to the winds? |
| cord-009664-kb9fnbgy | PBP 3 − SOS response? |
| cord-009664-kb9fnbgy | Patient management: the era of rapid diagnostic results( Symposium organised by Cepheid) S161 Will community MRSA and Clostridium difficile change infection control in hospitals? |
| cord-009664-kb9fnbgy | S485 Is culture still the gold standard, really? |
| cord-009664-kb9fnbgy | Should we oppose or cooperate? |
| cord-009664-kb9fnbgy | So, it is unclear how the transcription and translation of viral genes is influenced? |
| cord-009664-kb9fnbgy | The( r)evolution of clinical microbiology in Europe − is it good or bad? |
| cord-009664-kb9fnbgy | To what extent do patients benefit from translation of basic research into tools for clinical management? |
| cord-009664-kb9fnbgy | What about Europe? |
| cord-009664-kb9fnbgy | What is driving the evolution? |
| cord-009664-kb9fnbgy | or gyrA QRDR mutation frequencies than efflux negative isolates? |
| cord-009664-kb9fnbgy | which antifungal treatment for which patient? |